Annual CFI
-$2.11 M
-$1.76 M-513.40%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual cash flow from investing activities is currently -$2.11 million, with the most recent change of -$1.76 million (-513.40%) on 31 December 2023. During the last 3 years, it has fallen by -$1.73 million (-466.08%). GDTC annual CFI is now -513.40% below its all-time high of -$343.40 thousand, reached on 31 December 2022.GDTC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -513.4% | - | - |
| 3 y3 years | -466.1% | - | - |
| 5 y5 years | - | - | - |
GDTC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -513.4% | at low | ||||
| 5 y | 5 years | -513.4% | at low | ||||
| alltime | all time | -513.4% | at low |
CytoMed Therapeutics Limited Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$2.11 M(+513.4%) | - | - |
| Dec 2022 | -$343.40 K(-44.0%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$612.90 K(+64.7%) | - | - |
| Dec 2020 | -$372.10 K | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual cash flow from investing activities?
- What is the all time high annual CFI for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual CFI year-on-year change?
What is CytoMed Therapeutics Limited annual cash flow from investing activities?
The current annual CFI of GDTC is -$2.11 M
What is the all time high annual CFI for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual cash flow from investing activities is -$343.40 K
What is CytoMed Therapeutics Limited annual CFI year-on-year change?
Over the past year, GDTC annual cash flow from investing activities has changed by -$1.76 M (-513.40%)